FUREN Group Pharmaceutical Co Ltd
SSE:600781
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
FUREN Group Pharmaceutical Co Ltd
EPS (Diluted)
FUREN Group Pharmaceutical Co Ltd
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
F
|
FUREN Group Pharmaceutical Co Ltd
SSE:600781
|
EPS (Diluted)
-¥4
|
CAGR 3-Years
-318%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
EPS (Diluted)
¥0
|
CAGR 3-Years
28%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
EPS (Diluted)
¥1
|
CAGR 3-Years
25%
|
CAGR 5-Years
3%
|
CAGR 10-Years
11%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
EPS (Diluted)
¥2
|
CAGR 3-Years
20%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
1%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
EPS (Diluted)
¥2
|
CAGR 3-Years
24%
|
CAGR 5-Years
6%
|
CAGR 10-Years
26%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
EPS (Diluted)
¥9
|
CAGR 3-Years
N/A
|
CAGR 5-Years
241%
|
CAGR 10-Years
N/A
|
|
FUREN Group Pharmaceutical Co Ltd
Glance View
FUREN Group Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. The company is headquartered in Zhengzhou, Henan and currently employs 2,916 full-time employees. The firm's principal business is the manufacture of proprietary Chinese medicines, including capsules, tablets, granules, gels, injections, suspensions, drops, syrups and others. The firm mainly distributes its products in the domestic market.
See Also
What is FUREN Group Pharmaceutical Co Ltd's EPS (Diluted)?
EPS (Diluted)
-4.4
CNY
Based on the financial report for Mar 31, 2023, FUREN Group Pharmaceutical Co Ltd's EPS (Diluted) amounts to -4.4 CNY.
What is FUREN Group Pharmaceutical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-318%
Over the last year, the EPS (Diluted) growth was 17%. The average annual EPS (Diluted) growth rates for FUREN Group Pharmaceutical Co Ltd have been -318% over the past three years .
